# Study of Atropine Therapeutic Effect on Myopic Progression

> **NCT05529056** · PHASE3 · UNKNOWN · sponsor: **LitePharmTech Co., Ltd.** · enrollment: 472 (estimated)

## Conditions studied

- Myopia
- Children

## Interventions

- **DRUG:** Atropine Sulfate 01
- **DRUG:** Atropine Sulfate 02
- **DRUG:** Atropine Sulfate 03
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05529056
- **Lead sponsor:** LitePharmTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-25
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 472 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529056, "Study of Atropine Therapeutic Effect on Myopic Progression". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05529056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*